medigraphic.com

2019, Number 1

<< Back Next >>

Rev Mex Anest 2019; 42 (1)

Prevalence of postoperative nausea and vomiting in laparoscopic cholecystectomy at a third level of care

Robles-Espinoza GD, Martínez-Ramírez JS, Torres-Alarcón CG

Language: Spanish
References: 24
Page: 19-27
PDF size: 240.74 Kb.


ABSTRACT

Introduction: Postoperative nausea and vomiting are frequent complications of anesthesia, the prevention of this complication is fundamental from the pre-anesthetic period. Its etiology is multifactorial with variable prevalences ranging from 20 to 92%. Objective: To determine the prevalence of postoperative nausea and vomiting in laparoscopic cholecystectomy in a tertiary care hospital. Material and methods: An observational, descriptive, prospective and longitudinal study was conducted in patients who were scheduled for elective laparoscopic cholecystectomy in a tertiary care hospital, the presentation of nausea, vomiting and the combination of both symptoms was measured, upon awakening of the patient, the first, second and twenty-four postoperative. Results: 224 patients were included, of which the female sex represented 75.45%, with an average age of 44.4 ± 13.9 years. The prevalence of nausea in the first 24 hours was 33.03%. and it was preceded by vomiting in 93.24% of patients with a prevalence of 31.25%. the combination of both symptoms; postoperative nausea and vomiting, had a prevalence of 33.5%. The type of prophylactic medication that was received the majority was ondansetron with 48.86%, the prevalence of postoperative nausea and vomiting had no difference in the prophylactic treatment used. Treatment with opioids is one of the factors that was associated with a greater presentation of nausea and/or vomiting.


REFERENCES

  1. Shibli KU. Postoperative nausea and vomiting (PONV): a cause for concern. Anaesth Pain & Intensive Care. 2013;17:6-9.

  2. Andrews PL, Hawthorn J. The neurophysiology of vomiting. Baillieres Clin Gastroenterol. 1988;2:141-168.

  3. Horn CC. Why is the neurobiology of nausea and vomiting so important? Appetite. 2008;50:430-434.

  4. Apfel CC, Laara E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology. 1999;91:693-700.

  5. Mille LJE. Manejo actual de las náuseas y vómito postoperatorio. Rev Mex Anestesiol. 2011;34:231-234.

  6. Carrillo ER, Monteros EI, Nava JA. Náusea y vómito postoperatorio. Rev Mex Anestesiol. 2012;35:122-131.

  7. Nava JA. Tratamiento de la náusea y vómito postoperatorio en cirugía ambulatoria. Rev Mex Anestesiol. 2012;36:375-378.

  8. Kaye AD, Cornett EM, Chalabi J, Naim NZ, Novitch MB, Creel JB, et al. Pharmacology of antiemetics: update and current considerations in anesthesia practice. Anesthesiol Clin. 2017;35:e41-e54.

  9. Moon YE. Postoperative nausea and vomiting. Korean J Anesthesiol. 2014;67:164-170.

  10. Gan TJ, Diemunsch P, Habib AS, Kovac A, Kranke P, Meyer TA, et al. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2014;118:85-113.

  11. Milne RJ, Heel RC. Ondansetron. Therapeutic use as an antiemetic. Drugs. 1991;41:574-595.

  12. Tramèr MR, Reynolds DJ, Moore RA, McQuay HJ. Efficacy, dose-response, and safety of ondansetron in prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized placebo-controlled trials. Anesthesiology. 1997;87:1277-1289.

  13. Apfel CC, Roewer N, Korttila K. How to study postoperative nausea and vomiting. Acta Anaesthesiol Scand. 2002;46:921-928.

  14. Oriol SA, Arzate PR, Hernández CE, Castelazo JA. ¿Ondansetron o dexametasona? Tratamiento de náusea y vómito postoperatorios en cirugía abdominal. Rev Mex Anestesiol. 2009;32:163-170.

  15. Córdova LR, Castro LA, Bastidas CA. Estudio comparativo de náusea y vómito postoperatorio. Rev Mex Anestesiol. 2009;32:131-133.

  16. Mayeur C, Robin E, Kipnis E, Vallet B, Andrieu G, Fleyfel M, et al. Impact of a prophylactic strategy on the incidence of nausea and vomiting after general surgery. Ann Fr Anesth Reanim. 2012;31:e53-e57.

  17. Apfel CC, Heidrich FM, Jukar-Rao S, Jalota L, Hornuss C, Whelan RP, et al. Evidence-based analysis of risk factors for postoperative nausea and vomiting. Br J Anaesth. 2012;109:742-753.

  18. Henzi I, Walder B, Tramèr MR. Metoclopramide in the prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized, placebo-controlled studies. Br J Anaesth. 1999;83:761-771.

  19. Singla NK, Singla SK, Chung F, Kutsogiannis DJ, Blackburn L, Lane SR, et al. Phase II study to evaluate the safety and efficacy of the oral neurokinin-1 receptor antagonist casopitant (GW679769) administered with ondansetron for the prevention of postoperative and postdischarge nausea and vomiting in high-risk patients. Anesthesiology. 2010;113:74-82.

  20. Ziemann-Gimmel P, Goldfarb AA, Koppman J, Marema RT. Opioid-free total intravenous anaesthesia reduces postoperative nausea and vomiting in bariatric surgery beyond triple prophylaxis. Br J Anaesth. 2014;112:906-911.

  21. Andrews PL. Physiology of nausea and vomiting. Br J Anaesth. 1992;69:2S-19S.

  22. Janicki PK, Sugino S. Genetic factors associated with pharmacotherapy and background sensitivity to postoperative and chemotherapy-induced nausea and vomiting. Exp Brain Res. 2014;232:2613-2625.

  23. Rueffert H, Thieme V, Wallenborn J, Lemnitz N, Bergmann A, Rudlof K, et al. Do variations in the 5-HT3A and 5-HT3B serotonin receptor genes (HTR3A and HTR3B) influence the occurrence of postoperative vomiting? Anesth Analg. 2009;109:1442-1447.

  24. Nielsen M, Olsen NV. Genetic polymorphisms in the cytochrome P450 system and efficacy of 5-hydroxytryptamine type 3 receptor antagonists for postoperative nausea and vomiting. Br J Anaesth. 2008;101:441-415.




2020     |     www.medigraphic.com